TLR2 is associated with improved survival and premalignant regression in NSCLCin melanoma

This new paper in Cell Reports discusses the usibility of TLR2 expression for survival analysis in NSCLCin melanoma patients. They showed that TLR2 is highly expressed in tumor epithelium and correlates with improved survival and clinical regression

Previous post
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma Next post
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin